Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2008

01.02.2008 | Gastrointestinal Oncology

Impact of the Site of Anastomosis after Oncologic Esophagectomy on Quality of Life — A Prospective, Longitudinal Outcome Study

verfasst von: Jan-Hendrik Egberts, MD, Bodo Schniewind, MD, Beate Bestmann, PhD, MA, Clemens Schafmayer, MD, MBA, Friederike Egberts, MD, Fred Faendrich, MD, FRCS, Thomas Kuechler, PhD, Juergen Tepel, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

For patients undergoing oncologic surgery, the quality of life (QoL) is generally accepted as an important outcome parameter in addition to long-term survival, mortality, and complication rates. Our study focused on outcome in terms of QoL in patients with esophageal cancer, comparing the sites of anastomosis (cervical versus thoracic anastomosis).

Methods

In a prospective longitudinal single-center study from 1998 to 2005, 105 patients underwent surgery for esophageal cancer. To assess QoL the EORTC-QLQ-C-30 and a tumor-specific module were administered before surgery, at discharge, and three, six, 12, and 24 months after surgery. Clinical data were collected prospectively and follow-up was performed every six months.

Results

The histological type was squamous cell carcinoma in 51.4% of the cases, adenocarcinoma in 41.9%, and some other type in 6.7%. There was no significant difference between cervical and thoracic anastomosis with regard to morbidity, mortality, and survival rates (30% five-year survival rate), whereas tumor stage was a significant (p < 0.001) prognostic factor. Most QoL scores dropped significantly below baseline in the early postoperative period. Even though they recovered slowly during the follow-up period, they never reached preoperative levels again. There was no statistically significant difference in any of the QoL scales between patients with a cervical or a thoracic anastomosis.

Conclusions

Esophageal resections are associated with significant deterioration of QoL, which persists during the follow-up period. The surgical technique and position of the esophagogastrostomy did not affect QoL deterioration.
Literatur
1.
Zurück zum Zitat Wijnhoven BP, Tran KT, Esterman A, et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007;245(5):717–25PubMedCrossRef Wijnhoven BP, Tran KT, Esterman A, et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007;245(5):717–25PubMedCrossRef
2.
Zurück zum Zitat Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001;72(1):306–13PubMedCrossRef Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001;72(1):306–13PubMedCrossRef
3.
Zurück zum Zitat Sundelof M, Ye W, Dickman PW, Lagergren J. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer 2002;99(5):751–4PubMedCrossRef Sundelof M, Ye W, Dickman PW, Lagergren J. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer 2002;99(5):751–4PubMedCrossRef
4.
Zurück zum Zitat Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347(21):1662–9PubMedCrossRef Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347(21):1662–9PubMedCrossRef
5.
Zurück zum Zitat Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4(8):481–8PubMedCrossRef Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4(8):481–8PubMedCrossRef
7.
Zurück zum Zitat Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review. Am J Surg 1995;169(6):634–40PubMedCrossRef Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review. Am J Surg 1995;169(6):634–40PubMedCrossRef
8.
Zurück zum Zitat Walther B, Johansson J, Johnsson F, et al. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg 2003;238(6):803–12; discussion 812–4PubMedCrossRef Walther B, Johansson J, Johnsson F, et al. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg 2003;238(6):803–12; discussion 812–4PubMedCrossRef
9.
Zurück zum Zitat Lam TC, Fok M, Cheng SW, Wong J. Anastomotic complications after esophagectomy for cancer. A comparison of neck and chest anastomoses. J Thorac Cardiovasc Surg 1992;104(2):395–400PubMed Lam TC, Fok M, Cheng SW, Wong J. Anastomotic complications after esophagectomy for cancer. A comparison of neck and chest anastomoses. J Thorac Cardiovasc Surg 1992;104(2):395–400PubMed
10.
Zurück zum Zitat Muller JM, Erasmi H, Stelzner M, et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77(8):845–57PubMedCrossRef Muller JM, Erasmi H, Stelzner M, et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77(8):845–57PubMedCrossRef
11.
Zurück zum Zitat Patil PK, Patel SG, Mistry RC, et al. Cancer of the esophagus: esophagogastric anastomotic leak–a retrospective study of predisposing factors. J Surg Oncol 1992;49(3):163–7PubMedCrossRef Patil PK, Patel SG, Mistry RC, et al. Cancer of the esophagus: esophagogastric anastomotic leak–a retrospective study of predisposing factors. J Surg Oncol 1992;49(3):163–7PubMedCrossRef
12.
Zurück zum Zitat Chasseray VM, Kiroff GK, Buard JL, Launois B. Cervical or thoracic anastomosis for esophagectomy for carcinoma. Surg Gynecol Obstet 1989;169(1):55–62PubMed Chasseray VM, Kiroff GK, Buard JL, Launois B. Cervical or thoracic anastomosis for esophagectomy for carcinoma. Surg Gynecol Obstet 1989;169(1):55–62PubMed
13.
Zurück zum Zitat Dewar L, Gelfand G, Finley RJ, et al. Factors affecting cervical anastomotic leak and stricture formation following esophagogastrectomy and gastric tube interposition. Am J Surg 1992;163(5):484–9PubMedCrossRef Dewar L, Gelfand G, Finley RJ, et al. Factors affecting cervical anastomotic leak and stricture formation following esophagogastrectomy and gastric tube interposition. Am J Surg 1992;163(5):484–9PubMedCrossRef
14.
Zurück zum Zitat Fok M, Law S, Stipa F, et al. A comparison of transhiatal and transthoracic resection for oesophageal carcinoma. Endoscopy 1993;25(9):660–3PubMedCrossRef Fok M, Law S, Stipa F, et al. A comparison of transhiatal and transthoracic resection for oesophageal carcinoma. Endoscopy 1993;25(9):660–3PubMedCrossRef
15.
Zurück zum Zitat Iannettoni MD, Whyte RI, Orringer MB. Catastrophic complications of the cervical esophagogastric anastomosis. J Thorac Cardiovasc Surg 1995;110(5):1493–500; discussion 1500–1PubMedCrossRef Iannettoni MD, Whyte RI, Orringer MB. Catastrophic complications of the cervical esophagogastric anastomosis. J Thorac Cardiovasc Surg 1995;110(5):1493–500; discussion 1500–1PubMedCrossRef
16.
Zurück zum Zitat McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997;63(6):1568–72PubMedCrossRef McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997;63(6):1568–72PubMedCrossRef
17.
Zurück zum Zitat Schmidt CE, Bestmann B, Kuchler T, et al. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg 2004;28(4):355–60PubMedCrossRef Schmidt CE, Bestmann B, Kuchler T, et al. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg 2004;28(4):355–60PubMedCrossRef
18.
Zurück zum Zitat Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000;88(8):1781–7PubMedCrossRef Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000;88(8):1781–7PubMedCrossRef
19.
Zurück zum Zitat Brooks JA, Kesler KA, Johnson CS, et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002;81(4):185–94PubMedCrossRef Brooks JA, Kesler KA, Johnson CS, et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002;81(4):185–94PubMedCrossRef
20.
Zurück zum Zitat Baba M, Aikou T, Natsugoe S, et al. Appraisal of ten-year survival following esophagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg 1997;21(3):282–5; discussion 286PubMedCrossRef Baba M, Aikou T, Natsugoe S, et al. Appraisal of ten-year survival following esophagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg 1997;21(3):282–5; discussion 286PubMedCrossRef
21.
Zurück zum Zitat de Boer AG, van Lanschot JJ, van Sandick JW, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004;22(20):4202–8PubMedCrossRef de Boer AG, van Lanschot JJ, van Sandick JW, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004;22(20):4202–8PubMedCrossRef
22.
Zurück zum Zitat Velanovich V. The quality of quality of life studies in general surgical journals. J Am Coll Surg 2001;193(3):288–96PubMedCrossRef Velanovich V. The quality of quality of life studies in general surgical journals. J Am Coll Surg 2001;193(3):288–96PubMedCrossRef
23.
Zurück zum Zitat Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006;17(5):827–34PubMedCrossRef Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006;17(5):827–34PubMedCrossRef
24.
Zurück zum Zitat Blazeby JM, Williams MH, Brookes ST, et al. Quality of life measurement in patients with oesophageal cancer. Gut 1995;37(4):505–8PubMedCrossRef Blazeby JM, Williams MH, Brookes ST, et al. Quality of life measurement in patients with oesophageal cancer. Gut 1995;37(4):505–8PubMedCrossRef
25.
Zurück zum Zitat Lipscomb J, Donaldson MS, Arora NK, et al. Cancer outcomes research. J Natl Cancer Inst Monogr 2004;33:178–97PubMedCrossRef Lipscomb J, Donaldson MS, Arora NK, et al. Cancer outcomes research. J Natl Cancer Inst Monogr 2004;33:178–97PubMedCrossRef
26.
Zurück zum Zitat Beitz J, Gnecco C, Justice R. Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective. J Natl Cancer Inst Monogr 1996;20:7–9PubMed Beitz J, Gnecco C, Justice R. Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective. J Natl Cancer Inst Monogr 1996;20:7–9PubMed
27.
Zurück zum Zitat Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985;69(10):1155–9PubMed Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985;69(10):1155–9PubMed
28.
Zurück zum Zitat Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85(11):1457–9PubMedCrossRef Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85(11):1457–9PubMedCrossRef
29.
Zurück zum Zitat Kuechler T. Quality of life research in oncology. Quality of life and health: concepts, methods and applications. Vienna: Blackwell Wissenschafts-Verlag, 1995:89–96 Kuechler T. Quality of life research in oncology. Quality of life and health: concepts, methods and applications. Vienna: Blackwell Wissenschafts-Verlag, 1995:89–96
30.
Zurück zum Zitat Fayers B, Curran D, Groenvold M. EORTC QLQ-C30 Scoring manual. 2nd ed.1999 Fayers B, Curran D, Groenvold M. EORTC QLQ-C30 Scoring manual. 2nd ed.1999
31.
Zurück zum Zitat Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37(11):1345–51PubMedCrossRef Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37(11):1345–51PubMedCrossRef
32.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16(1):139–44PubMed Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16(1):139–44PubMed
34.
Zurück zum Zitat Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003;39(10):1384–94PubMedCrossRef Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003;39(10):1384–94PubMedCrossRef
35.
Zurück zum Zitat Stein HJ, von Rahden BH, Siewert JR. Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg 2005;390(4):280–5PubMedCrossRef Stein HJ, von Rahden BH, Siewert JR. Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg 2005;390(4):280–5PubMedCrossRef
36.
Zurück zum Zitat Zieren HU, Jacobi CA, Zieren J, Muller JM. Quality of life following resection of oesophageal carcinoma. Br J Surg 1996;83(12):1772–5PubMedCrossRef Zieren HU, Jacobi CA, Zieren J, Muller JM. Quality of life following resection of oesophageal carcinoma. Br J Surg 1996;83(12):1772–5PubMedCrossRef
37.
Zurück zum Zitat Viklund P, Wengstrom Y, Rouvelas I, et al. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006;42(10):1407–14PubMedCrossRef Viklund P, Wengstrom Y, Rouvelas I, et al. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006;42(10):1407–14PubMedCrossRef
38.
Zurück zum Zitat van Knippenberg FC, Out JJ, Tilanus HW, et al. Quality of Life in patients with resected oesophageal cancer. Soc Sci Med 1992;35(2):139–45PubMedCrossRef van Knippenberg FC, Out JJ, Tilanus HW, et al. Quality of Life in patients with resected oesophageal cancer. Soc Sci Med 1992;35(2):139–45PubMedCrossRef
39.
Zurück zum Zitat Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001;49(2):227–30PubMedCrossRef Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001;49(2):227–30PubMedCrossRef
40.
Zurück zum Zitat Urschel JD. Esophagogastric anastomotic leaks: the importance of gastric ischemia and therapeutic applications of gastric conditioning. J Invest Surg 1998;11(4):245–50PubMedCrossRef Urschel JD. Esophagogastric anastomotic leaks: the importance of gastric ischemia and therapeutic applications of gastric conditioning. J Invest Surg 1998;11(4):245–50PubMedCrossRef
41.
Zurück zum Zitat Blewett CJ, Miller JD, Young JE, et al. Anastomotic leaks after esophagectomy for esophageal cancer: a comparison of thoracic and cervical anastomoses. Ann Thorac Cardiovasc Surg 2001;7(2):75–8PubMed Blewett CJ, Miller JD, Young JE, et al. Anastomotic leaks after esophagectomy for esophageal cancer: a comparison of thoracic and cervical anastomoses. Ann Thorac Cardiovasc Surg 2001;7(2):75–8PubMed
42.
Zurück zum Zitat Deschamps C, Nichols FC 3rd, Cassivi SD, et al. Long-term function and quality of life after esophageal resection for cancer and Barrett’s. Surg Clin North Am 2005;85(3):649–56, xiPubMedCrossRef Deschamps C, Nichols FC 3rd, Cassivi SD, et al. Long-term function and quality of life after esophageal resection for cancer and Barrett’s. Surg Clin North Am 2005;85(3):649–56, xiPubMedCrossRef
43.
Zurück zum Zitat Schniewind B, Bestmann B, Kurdow R, et al. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Ann Surg Oncol 2006;13(11):1403–11PubMedCrossRef Schniewind B, Bestmann B, Kurdow R, et al. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Ann Surg Oncol 2006;13(11):1403–11PubMedCrossRef
44.
Zurück zum Zitat Schmidt CE, Bestmann B, Kuchler T, et al. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol 2005;12(2):117–23PubMedCrossRef Schmidt CE, Bestmann B, Kuchler T, et al. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol 2005;12(2):117–23PubMedCrossRef
45.
Zurück zum Zitat Kahlke V, Bestmann B, Schmid A, et al. Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World J Surg 2004;28(4):369–75PubMedCrossRef Kahlke V, Bestmann B, Schmid A, et al. Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World J Surg 2004;28(4):369–75PubMedCrossRef
46.
Zurück zum Zitat Sprangers MA, Van Dam FS, Broersen J, et al. Revealing response shift in longitudinal research on fatigue–the use of the thentest approach. Acta Oncol 1999;38(6):709–18PubMedCrossRef Sprangers MA, Van Dam FS, Broersen J, et al. Revealing response shift in longitudinal research on fatigue–the use of the thentest approach. Acta Oncol 1999;38(6):709–18PubMedCrossRef
47.
Zurück zum Zitat de Boer AG, van Lanschot JJ, Stalmeier PF, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004;13(2):311–20PubMedCrossRef de Boer AG, van Lanschot JJ, Stalmeier PF, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004;13(2):311–20PubMedCrossRef
48.
Zurück zum Zitat de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990;62(6):1034–8PubMed de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990;62(6):1034–8PubMed
49.
Zurück zum Zitat Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 1981;34(12):585–97PubMedCrossRef Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 1981;34(12):585–97PubMedCrossRef
50.
Zurück zum Zitat Blazeby JM, Alderson D, Winstone K, et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer 1996;32A(11):1912–7PubMedCrossRef Blazeby JM, Alderson D, Winstone K, et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer 1996;32A(11):1912–7PubMedCrossRef
Metadaten
Titel
Impact of the Site of Anastomosis after Oncologic Esophagectomy on Quality of Life — A Prospective, Longitudinal Outcome Study
verfasst von
Jan-Hendrik Egberts, MD
Bodo Schniewind, MD
Beate Bestmann, PhD, MA
Clemens Schafmayer, MD, MBA
Friederike Egberts, MD
Fred Faendrich, MD, FRCS
Thomas Kuechler, PhD
Juergen Tepel, MD
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9615-1

Weitere Artikel der Ausgabe 2/2008

Annals of Surgical Oncology 2/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.